Enzon Pharmaceuticals, Inc.
ENZN
$0.04
-$0.01-13.33%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.24% | -4.19% | -2.22% | -0.33% | 0.16% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 21.96% | 8.56% | 15.38% | -11.48% | 2.43% |
| Total Current Assets | -7.03% | -4.07% | -2.04% | -0.40% | 0.18% |
|
|
|||||
| Total Current Assets | -7.03% | -4.07% | -2.04% | -0.40% | 0.18% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -91.50% | -88.20% | -- | -95.26% | 175.68% |
| Total Assets | -7.58% | -4.71% | -2.79% | -1.12% | 0.59% |
|
|
|||||
| Total Accounts Payable | 0.00% | 0.00% | 0.00% | 0.00% | -1.78% |
| Total Accrued Expenses | -33.66% | 5.08% | 19.57% | -27.17% | 50.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2,266.67% | 1,950.00% | -50.00% | -0.85% | 200.00% |
| Total Other Current Liabilities | 2,266.67% | 1,950.00% | -50.00% | -0.85% | 200.00% |
| Total Current Liabilities | 23.29% | 95.85% | 6.33% | -2.10% | 7.88% |
|
|
|||||
| Total Current Liabilities | 23.29% | 95.85% | 6.33% | -2.10% | 7.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.29% | 95.85% | 6.33% | -2.10% | 7.88% |
|
|
|||||
| Common Stock & APIC | -1.76% | -1.74% | -1.73% | -1.72% | -1.73% |
| Retained Earnings | -3.45% | -1.90% | -0.09% | 1.10% | 2.13% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -133.42% | -85.78% | -40.71% | -14.18% | 9.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -133.42% | -85.78% | -40.71% | -14.18% | 9.82% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.87% | -5.60% | -2.90% | -1.08% | 0.53% |
|
|
|||||